You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 17, May 5, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Medical Ethics
 •Alert me on articles by topic

Conception for Donation

Norman C. Fost, MD, MPH

JAMA. 2004;291:2125-2126.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Preimplantation genetic diagnosis (PGD) of embryos created by in vitro fertilization (IVF) has become an increasingly available option for couples seeking to avoid the birth of a child with a genetic disorder. While opposed by some, PGD is less contentious and emotionally less stressful than prenatal diagnosis and abortion after pregnancy has begun and has resulted in the births of approximately 1000 children over the past decade.1

Sometimes couples seek PGD to accomplish 2 goals simultaneously: to facilitate creation of a child who will not only be healthy but also can become a source of hematologic stem cells, generally obtained from cord blood, which can be used to treat a sibling with a life-threatening hematologic disorder, such as Fanconi anemia or leukemia. In their report in this issue of THE JOURNAL, Verlinsky and colleagues2 report PGD with HLA testing in 9 families wanting a child . . . [Full Text of this Article]

Author Affiliations: Department of Pediatrics, Department of Medical History and Bioethics, University of Wisconsin Medical School, Madison.


RELATED LETTERS

Preimplantation Testing to Produce an HLA-Matched Donor Infant
Anders Fasth and Jan Wahlström
JAMA. 2004;292(7):803.
EXTRACT | FULL TEXT  

Preimplantation Testing to Produce an HLA-Matched Donor Infant
John E. Wagner, Jeffrey P. Kahn, Susan M. Wolf, and Jeffrey M. Lipton
JAMA. 2004;292(7):803-804.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Preimplantation HLA Testing
Yury Verlinsky, Svetlana Rechitsky, Tatyana Sharapova, Randy Morris, Mohammed Taranissi, and Anver Kuliev
JAMA. 2004;291(17):2079-2085.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Britain's new preimplantation tissue typing policy: an ethical defence
Ram
J. Med. Ethics 2006;32:278-282.
FULL TEXT  

Preimplantation Genetics: Improving Access to Stem Cell Therapy
KULIEV et al.
Ann. N. Y. Acad. Sci. 2005;1054:223-227.
ABSTRACT | FULL TEXT  

Preimplantation Testing to Produce an HLA-Matched Donor Infant
Fasth and Wahlstrom
JAMA 2004;292:803-803.
FULL TEXT  

Preimplantation Testing to Produce an HLA-Matched Donor Infant
Wagner et al.
JAMA 2004;292:803-804.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.